Mark M Davis Selected Research

Mark M Davis Research Topics

Disease

25	Infections 01/2022 - 02/2011
21	Neoplasms (Cancer) 07/2022 - 12/2003
20	Human Influenza (Influenza) 01/2022 - 02/2011
12	COVID-19 01/2022 - 07/2020
8	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 08/2013
7	Communicable Diseases (Infectious Diseases) 01/2020 - 10/2009
6	Inflammation (Inflammations) 01/2022 - 03/2006
4	Celiac Disease (Celiac Sprue) 01/2022 - 08/2013
4	Narcolepsy 01/2020 - 12/2013
3	Disease Progression 01/2022 - 01/2021
3	Tuberculosis (Tuberculoses) 01/2021 - 01/2017
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2019 - 03/2015
2	Fibrosis (Cirrhosis) 01/2022 - 01/2022
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2020
2	Bacterial Infections (Bacterial Infection) 01/2020 - 12/2003
2	Hypersensitivity (Allergy) 01/2019 - 03/2016
2	Systemic Scleroderma (Systemic Sclerosis) 01/2019 - 01/2017
2	Growth Disorders 01/2019 - 11/2018
2	Melanoma (Melanoma, Malignant) 01/2018 - 10/2005
2	Malaria 01/2018 - 01/2018
1	Myocarditis (Carditis) 07/2022
1	Rheumatoid Arthritis 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Type 2 Diabetes Mellitus (MODY) 01/2022
1	Viremia 01/2022
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2022
1	Chronic Pancreatitis 01/2022
1	Vesicular Stomatitis 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2021
1	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2021
1	Persistent Infection 01/2021
1	Cardiotoxicity 01/2021
1	Colitis 11/2020
1	Hypoxia (Hypoxemia) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Porcine Reproductive and Respiratory Syndrome (PRRS) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Hepatitis C 01/2020

Drug/Important Bio-Agent (IBA)

26	VaccinesIBA 01/2022 - 10/2009
21	AntigensIBA 01/2022 - 07/2002
15	AntibodiesIBA 01/2022 - 10/2005
13	Peptides (Polypeptides)IBA 01/2021 - 03/2003
12	EpitopesIBA 07/2022 - 12/2003
11	CytokinesIBA 01/2022 - 10/2005
9	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2013
6	Messenger RNA (mRNA)IBA 01/2022 - 04/2021
5	RNA (Ribonucleic Acid)IBA 07/2022 - 10/2014
5	mRNA VaccinesIBA 01/2022 - 04/2021
4	Immune Checkpoint InhibitorsIBA 07/2022 - 12/2018
4	ChemokinesIBA 07/2022 - 03/2006
4	T-Cell Antigen Receptors (T-Cell Receptor)IBA 07/2022 - 01/2019
4	Immunoglobulin G (IgG)IBA 01/2022 - 02/2011
4	HLA Antigens (Human Leukocyte Antigens)IBA 10/2021 - 12/2013
4	OrexinsIBA 01/2020 - 12/2013
4	Influenza Vaccines (Influenza Vaccine)FDA Link 01/2018 - 01/2013
3	Neutralizing AntibodiesIBA 01/2022 - 04/2015
3	Antigen-Antibody Complex (Immune Complex)IBA 01/2022 - 10/2014
3	COVID-19 VaccinesIBA 01/2022 - 12/2021
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2009
3	Immunoglobulins (Immunoglobulin)IBA 01/2019 - 01/2017
3	Hemagglutinins (Hemagglutinin)IBA 04/2015 - 01/2013
2	Monoclonal AntibodiesIBA 07/2022 - 07/2014
2	KIR ReceptorsIBA 01/2022 - 12/2021
2	BNT162 VaccineIBA 01/2022 - 04/2021
2	LipidsIBA 01/2022 - 01/2022
2	GliadinIBA 01/2022 - 12/2021
2	InterleukinsIBA 10/2021 - 12/2019
2	Antiviral Agents (Antivirals)IBA 04/2021 - 01/2017
2	Immunoglobulin A (IgA)IBA 04/2021 - 02/2011
2	Interleukin-17 (Interleukin 17)IBA 01/2021 - 03/2015
2	LigandsIBA 01/2019 - 01/2017
2	Glutens (Glutelin)IBA 01/2019 - 08/2013
2	Protein Subunit VaccinesIBA 01/2013 - 10/2005
1	Complement System Proteins (Complement)IBA 07/2022
1	AmphiregulinIBA 01/2022
1	BIBP COVID-19 vaccineIBA 01/2022
1	Rifaximin (L 105)FDA Link 01/2022
1	Viral AntigensIBA 01/2022
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2022
1	KynurenineIBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	IgG Receptors (Fc gamma RI)IBA 01/2022
1	Simvastatin (Zocor)FDA LinkGeneric 01/2022
1	HLA-DR alpha-ChainsIBA 01/2022
1	Interferon Type IIBA 06/2021
1	SARS-CoV-2 spike proteinIBA 04/2021
1	Immunoglobulin M (IgM)IBA 04/2021
1	ChromatinIBA 01/2021
1	HLA-DR Antigens (HLA-DR)IBA 01/2021
1	GoldIBA 01/2021
1	Biological ProductsIBA 01/2021
1	Blocking AntibodiesIBA 11/2020
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2020
1	Pattern Recognition ReceptorsIBA 01/2020
1	Angiotensin-Converting Enzyme 2IBA 01/2020

Therapy/Procedure

10	Immunotherapy 01/2021 - 10/2009
5	Therapeutics 01/2022 - 01/2017
2	Transplantation 03/2016 - 10/2013
1	Hematopoietic Stem Cell Transplantation 10/2021
1	Organ Transplantation 10/2021